Tag: Sanofi

Type 1 Diabetes Treatment Gets Landmark NHS Approval

June 24, 2026

Type 1 Diabetes Treatment Gets Landmark NHS Approval

FDA Approves Teplizumab for Children With Stage 3 Type 1 Diabetes – Despite Delays & Controversy

June 15, 2026

FDA Approves Teplizumab for Children With Stage 3 Type 1 Diabetes – Despite Delays & Controversy

Comprehensive Marketing Services for Global and Government Sectors

May 12, 2026

Comprehensive Marketing Services for Global and Government Sectors

List of 9 Pharmaceutical Giants Bow to Trump to Cut Drug Prices

December 20, 2025

List of 9 Pharmaceutical Giants Bow to Trump to Cut Drug Prices

Rilzabrutinib Approved: BTK Inhibitor for Immune Thrombocytopenia

September 2, 2025

Rilzabrutinib Approved: BTK Inhibitor for Immune Thrombocytopenia

Orphan Drug Designation for Multiple Myeloma Patients

August 1, 2025

Orphan Drug Designation for Multiple Myeloma Patients

Isatuximab Delivery: New Myeloma Treatment Option?

June 9, 2025

Isatuximab Delivery: New Myeloma Treatment Option?

Web Analytics Made Easy - Statcounter